Cracking The Code: Understanding Analyst Reviews For Tandem Diabetes Care
Cracking The Code: Understanding Analyst Reviews For Tandem Diabetes Care
破解密碼：了解分析師對 Tandem 糖尿病護理的評論
Ratings for Tandem Diabetes Care (NASDAQ:TNDM) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在過去三個月中，有5位分析師提供了Tandem Diabetes Care（納斯達克股票代碼：TNDM）的評級，顯示了看漲和看跌的觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他們最近的評級，簡要介紹了過去30天中不斷變化的情緒，並將其與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $34.0, a high estimate of $40.00, and a low estimate of $24.00. This current average has increased by 26.87% from the previous average price target of $26.80.
分析師分析的12個月目標股價提供了見解，平均目標價爲34.0美元，最高估計爲40.00美元，低估值爲24.00美元。目前的平均價格較之前的26.80美元的平均目標股價上漲了26.87％。
Breaking Down Analyst Ratings: A Detailed Examination
分解分析師評級：詳細審查
The standing of Tandem Diabetes Care among financial...
通過對分析師近期...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。